Further characterization of the consequences of PAH2 inhibition should also focus on whether this impacts function of the breast cancer oncoprotein EMSY, which has been shown to interact with PF1 and, more recently, KDM5B to repress expression of the anti-metastatic microRNA miR-31 [25, 29]. The gene discussed is PHF12; the disease is breast cancer.